ARCHIVES

An “insurgency” targets randomized trials, demands access to investigational drugs.

This article is from The Cancer Letter archive.

Vol. 31 No. 31 | August 5, 2005

Download PDF Visit The Full Archive

Related Articles

SPOREs In Breast, Prostate Cancers Win $12.7 Million.

October 6, 2000

DCCP Board Approves Concept Of RFA, New, Competing Contracts

October 15, 1982

Clinical Trials Approved By NCI Last Month Are Listed

January 25, 2002

Timothy Talbot, Fox Chase Founder, Centers Advocate, Dies At Age 72

November 11, 1988

European Compound enhances IL-2 In BRMP Mouse Study; BRMP Mouse Study; Rosemberg Describes System Improvements, Updates Results

June 5, 1987

NCI Sets Initial R01 Payline At 18th Percentile Under CR.

November 24, 2000